Clinical Trials Browser

Phase 1 × Active not recruiting × sacituzumab govitecan × Clear all

NCT05143229 2026-05-01

ASSET

Phase 1 Active not recruiting

Breast Neoplasms, Neoplasm Metastasis

NCT04794699 2026-04-09

Study of IDE397 in Participants With Solid Tumors Harboring MTAP Deletion

Phase 1 Active not recruiting

GenitourinaryThoracic

Urinary Bladder Neoplasms, Lung Neoplasms